Papua New Guinea

Papua New Guinea

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
6.2 (5.82 - 6.47) 2019 Modelled IHME
6.34 (5.98 - 6.62) 2018 Modelled IHME
6.45 (6.01 - 6.77) 2017 Modelled IHME
6.51 (5.98 - 6.85) 2016 Modelled IHME
6.58 (5.80 - 6.96) 2015 Modelled IHME
6.68 (5.87 - 7.07) 2014 Modelled IHME
6.82 (6.04 - 7.21) 2013 Modelled IHME
6.98 (6.24 - 7.37) 2012 Modelled IHME
7.15 (6.41 - 7.54) 2011 Modelled IHME
7.3 (6.55 - 7.72) 2010 Modelled IHME
7.46 (6.72 - 7.87) 2009 Modelled IHME
7.61 (6.84 - 8.04) 2008 Modelled IHME
7.77 (6.93 - 8.23) 2007 Modelled IHME
7.92 (7.04 - 8.41) 2006 Modelled IHME
8.06 (7.15 - 8.59) 2005 Modelled IHME
8.19 (7.19 - 8.73) 2004 Modelled IHME
8.31 (7.24 - 8.88) 2003 Modelled IHME
8.43 (7.31 - 9.02) 2002 Modelled IHME
8.55 (7.35 - 9.16) 2001 Modelled IHME
8.68 (7.40 - 9.34) 2000 Modelled IHME
8.81 (7.51 - 9.51) 1999 Modelled IHME
8.95 (7.57 - 9.69) 1998 Modelled IHME
9.09 (7.67 - 9.89) 1997 Modelled IHME
9.23 (7.77 - 10.10) 1996 Modelled IHME
9.36 (7.88 - 10.30) 1995 Modelled IHME
9.49 (7.96 - 10.43) 1994 Modelled IHME
9.63 (8.07 - 10.53) 1993 Modelled IHME
9.76 (8.20 - 10.64) 1992 Modelled IHME
9.9 (8.34 - 10.77) 1991 Modelled IHME
10.03 (8.40 - 10.92) 1990 Modelled IHME
5.4 (4.34 - 6.79) 2015 Modelled WHO
6.6 (6 - 7.70) 2016 Modelled Razavi-Shearer et al, 2018
14.59 (13.85 - 15.35) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.57 (1.89 - 3.15) 2019 Modelled IHME
2.64 (1.91 - 3.20) 2018 Modelled IHME
2.66 (1.88 - 3.28) 2017 Modelled IHME
2.5 (1.63 - 3.09) 2016 Modelled IHME
2.33 (1.35 - 2.98) 2015 Modelled IHME
2.31 (1.35 - 2.95) 2014 Modelled IHME
2.3 (1.36 - 2.93) 2013 Modelled IHME
2.29 (1.38 - 2.91) 2012 Modelled IHME
2.29 (1.38 - 2.89) 2011 Modelled IHME
2.29 (1.40 - 2.90) 2010 Modelled IHME
2.28 (1.41 - 2.89) 2009 Modelled IHME
2.27 (1.43 - 2.89) 2008 Modelled IHME
2.27 (1.46 - 2.91) 2007 Modelled IHME
2.26 (1.47 - 2.93) 2006 Modelled IHME
2.27 (1.49 - 2.94) 2005 Modelled IHME
2.33 (1.57 - 3.05) 2004 Modelled IHME
2.48 (1.67 - 3.21) 2003 Modelled IHME
2.7 (1.81 - 3.44) 2002 Modelled IHME
2.95 (1.97 - 3.69) 2001 Modelled IHME
3.2 (2.12 - 4.02) 2000 Modelled IHME
3.49 (2.30 - 4.39) 1999 Modelled IHME
3.85 (2.53 - 4.86) 1998 Modelled IHME
4.23 (2.77 - 5.40) 1997 Modelled IHME
4.58 (3 - 5.87) 1996 Modelled IHME
4.87 (3.22 - 6.30) 1995 Modelled IHME
5.1 (3.40 - 6.51) 1994 Modelled IHME
5.31 (3.54 - 6.72) 1993 Modelled IHME
5.5 (3.71 - 6.92) 1992 Modelled IHME
5.67 (3.79 - 7.06) 1991 Modelled IHME
5.8 (3.86 - 7.22) 1990 Modelled IHME
2.24 (1.68 - 2.85) 2015 Modelled WHO
2.3 2013 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
409,904 (343,488 - 446,170) 1990 Modelled IHME
416,192 (350,604 - 452,978) 1991 Modelled IHME
422,712 (354,958 - 460,514) 1992 Modelled IHME
429,512 (360,088 - 469,758) 1993 Modelled IHME
436,602 (365,938 - 479,744) 1994 Modelled IHME
443,997 (373,867 - 488,479) 1995 Modelled IHME
451,497 (380,032 - 494,207) 1996 Modelled IHME
458,956 (387,387 - 499,372) 1997 Modelled IHME
466,367 (394,843 - 505,119) 1998 Modelled IHME
473,948 (404,192 - 511,742) 1999 Modelled IHME
481,951 (410,990 - 519,140) 2000 Modelled IHME
490,403 (421,840 - 525,630) 2001 Modelled IHME
499,136 (432,551 - 534,146) 2002 Modelled IHME
507,874 (442,616 - 542,315) 2003 Modelled IHME
516,328 (453,237 - 550,541) 2004 Modelled IHME
524,191 (464,639 - 558,158) 2005 Modelled IHME
531,151 (472,022 - 563,875) 2006 Modelled IHME
537,288 (479,045 - 568,902) 2007 Modelled IHME
542,890 (487,438 - 573,611) 2008 Modelled IHME
548,245 (494,034 - 578,801) 2009 Modelled IHME
553,678 (496,642 - 585,401) 2010 Modelled IHME
558,472 (501,105 - 589,073) 2011 Modelled IHME
562,259 (502,264 - 593,398) 2012 Modelled IHME
566,094 (500,827 - 598,097) 2013 Modelled IHME
571,164 (501,245 - 604,142) 2014 Modelled IHME
578,739 (510,589 - 612,538) 2015 Modelled IHME
589,962 (541,498 - 620,301) 2016 Modelled IHME
601,194 (560,720 - 630,781) 2017 Modelled IHME
608,255 (573,493 - 635,036) 2018 Modelled IHME
611,710 (574,412 - 638,804) 2019 Modelled IHME
535,000 (482,000 - 621,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.93 (2.02 - 4.16) 2019 Modelled IHME
2.94 (2 - 4.21) 2018 Modelled IHME
2.92 (1.98 - 4.17) 2017 Modelled IHME
2.89 (1.95 - 4.05) 2016 Modelled IHME
2.91 (1.97 - 4.13) 2015 Modelled IHME
2.89 (1.95 - 4.10) 2014 Modelled IHME
2.92 (1.96 - 4.17) 2013 Modelled IHME
2.98 (2 - 4.22) 2012 Modelled IHME
3.03 (2.02 - 4.26) 2011 Modelled IHME
3.03 (2.04 - 4.25) 2010 Modelled IHME
3.02 (2.02 - 4.23) 2009 Modelled IHME
3.09 (2.06 - 4.27) 2008 Modelled IHME
3.15 (2.13 - 4.38) 2007 Modelled IHME
3.17 (2.17 - 4.37) 2006 Modelled IHME
3.19 (2.18 - 4.42) 2005 Modelled IHME
3.18 (2.19 - 4.42) 2004 Modelled IHME
3.2 (2.20 - 4.47) 2003 Modelled IHME
3.22 (2.22 - 4.54) 2002 Modelled IHME
3.24 (2.21 - 4.58) 2001 Modelled IHME
3.28 (2.23 - 4.68) 2000 Modelled IHME
3.35 (2.29 - 4.80) 1999 Modelled IHME
3.37 (2.30 - 4.80) 1998 Modelled IHME
3.38 (2.30 - 4.82) 1997 Modelled IHME
3.43 (2.34 - 4.89) 1996 Modelled IHME
3.46 (2.36 - 4.96) 1995 Modelled IHME
3.53 (2.44 - 5.11) 1994 Modelled IHME
3.63 (2.53 - 5.23) 1993 Modelled IHME
3.74 (2.57 - 5.40) 1992 Modelled IHME
3.82 (2.66 - 5.50) 1991 Modelled IHME
3.9 (2.67 - 5.66) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
289 (200 - 410) 2019 Modelled IHME
282 (192 - 404) 2018 Modelled IHME
272 (185 - 389) 2017 Modelled IHME
262 (177 - 367) 2016 Modelled IHME
256 (173 - 363) 2015 Modelled IHME
247 (166 - 350) 2014 Modelled IHME
242 (163 - 346) 2013 Modelled IHME
240 (161 - 340) 2012 Modelled IHME
237 (158 - 333) 2011 Modelled IHME
230 (154 - 322) 2010 Modelled IHME
222 (149 - 311) 2009 Modelled IHME
220 (147 - 304) 2008 Modelled IHME
218 (147 - 303) 2007 Modelled IHME
213 (145 - 293) 2006 Modelled IHME
207 (142 - 288) 2005 Modelled IHME
201 (138 - 278) 2004 Modelled IHME
195 (135 - 273) 2003 Modelled IHME
191 (132 - 269) 2002 Modelled IHME
186 (127 - 263) 2001 Modelled IHME
182 (124 - 260) 2000 Modelled IHME
180 (123 - 258) 1999 Modelled IHME
176 (120 - 250) 1998 Modelled IHME
171 (116 - 243) 1997 Modelled IHME
168 (115 - 239) 1996 Modelled IHME
164 (112 - 235) 1995 Modelled IHME
163 (112 - 235) 1994 Modelled IHME
162 (113 - 233) 1993 Modelled IHME
162 (111 - 234) 1992 Modelled IHME
161 (112 - 231) 1991 Modelled IHME
159 (109 - 231) 1990 Modelled IHME
1,067 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
48 (39 - 59) 2019 Modelled IHME
48 (39 - 59) 2018 Modelled IHME
48 (39 - 59) 2017 Modelled IHME
48 (39 - 58) 2016 Modelled IHME
48 (39 - 58) 2015 Modelled IHME
48 (39 - 58) 2014 Modelled IHME
48 (38 - 58) 2013 Modelled IHME
48 (39 - 58) 2012 Modelled IHME
48 (38 - 58) 2011 Modelled IHME
48 (38 - 58) 2010 Modelled IHME
48 (39 - 58) 2009 Modelled IHME
48 (39 - 58) 2008 Modelled IHME
48 (39 - 58) 2007 Modelled IHME
48 (39 - 58) 2006 Modelled IHME
48 (39 - 58) 2005 Modelled IHME
48 (39 - 58) 2004 Modelled IHME
48 (39 - 58) 2003 Modelled IHME
48 (38 - 57) 2002 Modelled IHME
48 (38 - 57) 2001 Modelled IHME
48 (38 - 57) 2000 Modelled IHME
48 (38 - 57) 1999 Modelled IHME
48 (38 - 57) 1998 Modelled IHME
48 (39 - 58) 1997 Modelled IHME
48 (38 - 58) 1996 Modelled IHME
48 (39 - 58) 1995 Modelled IHME
49 (39 - 59) 1994 Modelled IHME
49 (39 - 59) 1993 Modelled IHME
49 (40 - 59) 1992 Modelled IHME
49 (40 - 59) 1991 Modelled IHME
50 (40 - 60) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
25 2018 Survey/reported WHO/UNICEF
33 2017 Survey/reported WHO/UNICEF
35 2016 Survey/reported WHO/UNICEF
32 2015 Survey/reported WHO/UNICEF
31 2014 Survey/reported WHO/UNICEF
37 2013 Survey/reported WHO/UNICEF
35 2012 Survey/reported WHO/UNICEF
31 2011 Survey/reported WHO/UNICEF
31 2010 Survey/reported WHO/UNICEF
26 2009 Survey/reported WHO/UNICEF
27 2008 Survey/reported WHO/UNICEF
29 2007 Survey/reported WHO/UNICEF
35 2006 Survey/reported WHO/UNICEF
25 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
61 2018 Survey/reported WHO/UNICEF
62 2017 Survey/reported WHO/UNICEF
72 2016 Survey/reported WHO/UNICEF
73 2015 Survey/reported WHO/UNICEF
73 2014 Survey/reported WHO/UNICEF
79 2013 Survey/reported WHO/UNICEF
74 2012 Survey/reported WHO/UNICEF
72 2011 Survey/reported WHO/UNICEF
67 2010 Survey/reported WHO/UNICEF
66 2009 Survey/reported WHO/UNICEF
59 2008 Survey/reported WHO/UNICEF
61 2007 Survey/reported WHO/UNICEF
71 2006 Survey/reported WHO/UNICEF
63 2005 Survey/reported WHO/UNICEF
60 2004 Survey/reported WHO/UNICEF
67 2003 Survey/reported WHO/UNICEF
60 2002 Survey/reported WHO/UNICEF
59 2001 Survey/reported WHO/UNICEF
57 2000 Survey/reported WHO/UNICEF
54 1999 Survey/reported WHO/UNICEF
47 1998 Survey/reported WHO/UNICEF
44 1997 Survey/reported WHO/UNICEF
43 1996 Survey/reported WHO/UNICEF
23 1995 Survey/reported WHO/UNICEF
20 1994 Survey/reported WHO/UNICEF
7 1993 Survey/reported WHO/UNICEF
12 1992 Survey/reported WHO/UNICEF
19 1991 Survey/reported WHO/UNICEF
20 1990 Survey/reported WHO/UNICEF
35 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1998
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
None
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
None
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.01 (0.81 - 1.26) 2019 Modelled IHME
1.01 (0.80 - 1.26) 2018 Modelled IHME
1.01 (0.80 - 1.28) 2017 Modelled IHME
1.01 (0.81 - 1.26) 2016 Modelled IHME
1.01 (0.81 - 1.24) 2015 Modelled IHME
1.01 (0.81 - 1.25) 2014 Modelled IHME
1.02 (0.82 - 1.27) 2013 Modelled IHME
1.04 (0.83 - 1.29) 2012 Modelled IHME
1.06 (0.83 - 1.32) 2011 Modelled IHME
1.07 (0.84 - 1.35) 2010 Modelled IHME
1.09 (0.86 - 1.36) 2009 Modelled IHME
1.11 (0.89 - 1.38) 2008 Modelled IHME
1.14 (0.92 - 1.40) 2007 Modelled IHME
1.17 (0.94 - 1.43) 2006 Modelled IHME
1.2 (0.97 - 1.47) 2005 Modelled IHME
1.25 (1.01 - 1.52) 2004 Modelled IHME
1.3 (1.06 - 1.58) 2003 Modelled IHME
1.36 (1.11 - 1.66) 2002 Modelled IHME
1.42 (1.16 - 1.74) 2001 Modelled IHME
1.46 (1.19 - 1.81) 2000 Modelled IHME
1.5 (1.22 - 1.84) 1999 Modelled IHME
1.53 (1.25 - 1.87) 1998 Modelled IHME
1.56 (1.26 - 1.91) 1997 Modelled IHME
1.58 (1.26 - 1.94) 1996 Modelled IHME
1.59 (1.27 - 1.96) 1995 Modelled IHME
1.58 (1.26 - 1.93) 1994 Modelled IHME
1.54 (1.23 - 1.89) 1993 Modelled IHME
1.48 (1.18 - 1.82) 1992 Modelled IHME
1.4 (1.11 - 1.73) 1991 Modelled IHME
1.31 (1.03 - 1.63) 1990 Modelled IHME
1.2 (0.90 - 4.20) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
1.49 (1.12 - 5.20) 2019 Modelled Dugan et al., 2021
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
53,425 (42,235 - 66,664) 1990 Modelled IHME
58,841 (46,521 - 72,929) 1991 Modelled IHME
63,961 (50,965 - 78,945) 1992 Modelled IHME
68,589 (55,012 - 84,157) 1993 Modelled IHME
72,496 (58,013 - 88,716) 1994 Modelled IHME
75,424 (60,313 - 93,034) 1995 Modelled IHME
77,437 (61,845 - 94,894) 1996 Modelled IHME
78,874 (63,739 - 96,626) 1997 Modelled IHME
79,859 (65,255 - 97,669) 1998 Modelled IHME
80,577 (65,873 - 99,103) 1999 Modelled IHME
81,237 (66,334 - 100,637) 2000 Modelled IHME
81,380 (66,512 - 99,726) 2001 Modelled IHME
80,677 (65,887 - 98,187) 2002 Modelled IHME
79,565 (64,725 - 96,692) 2003 Modelled IHME
78,544 (63,466 - 95,693) 2004 Modelled IHME
78,184 (62,782 - 95,457) 2005 Modelled IHME
78,437 (63,056 - 95,924) 2006 Modelled IHME
78,855 (63,359 - 97,038) 2007 Modelled IHME
79,464 (63,311 - 98,334) 2008 Modelled IHME
80,285 (63,468 - 99,903) 2009 Modelled IHME
81,340 (63,859 - 102,468) 2010 Modelled IHME
82,469 (64,884 - 103,362) 2011 Modelled IHME
83,593 (66,630 - 103,932) 2012 Modelled IHME
84,883 (67,970 - 105,028) 2013 Modelled IHME
86,533 (69,434 - 106,638) 2014 Modelled IHME
88,749 (70,907 - 109,291) 2015 Modelled IHME
91,582 (73,047 - 113,739) 2016 Modelled IHME
94,503 (74,504 - 119,021) 2017 Modelled IHME
97,165 (77,211 - 121,274) 2018 Modelled IHME
99,687 (79,464 - 124,682) 2019 Modelled IHME
94,000 (70,000 - 328,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
33,000 (24,700 - 115,000) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.94 (1.27 - 2.79) 2019 Modelled IHME
1.94 (1.28 - 2.76) 2018 Modelled IHME
1.93 (1.27 - 2.78) 2017 Modelled IHME
1.93 (1.28 - 2.74) 2016 Modelled IHME
1.95 (1.29 - 2.83) 2015 Modelled IHME
1.93 (1.28 - 2.80) 2014 Modelled IHME
1.92 (1.29 - 2.78) 2013 Modelled IHME
1.93 (1.29 - 2.77) 2012 Modelled IHME
1.92 (1.29 - 2.75) 2011 Modelled IHME
1.89 (1.26 - 2.71) 2010 Modelled IHME
1.84 (1.23 - 2.61) 2009 Modelled IHME
1.84 (1.24 - 2.60) 2008 Modelled IHME
1.83 (1.23 - 2.59) 2007 Modelled IHME
1.81 (1.21 - 2.57) 2006 Modelled IHME
1.81 (1.22 - 2.54) 2005 Modelled IHME
1.79 (1.20 - 2.53) 2004 Modelled IHME
1.79 (1.18 - 2.54) 2003 Modelled IHME
1.79 (1.20 - 2.53) 2002 Modelled IHME
1.79 (1.19 - 2.54) 2001 Modelled IHME
1.81 (1.21 - 2.55) 2000 Modelled IHME
1.83 (1.22 - 2.60) 1999 Modelled IHME
1.83 (1.23 - 2.58) 1998 Modelled IHME
1.83 (1.23 - 2.57) 1997 Modelled IHME
1.84 (1.25 - 2.60) 1996 Modelled IHME
1.84 (1.25 - 2.64) 1995 Modelled IHME
1.86 (1.27 - 2.65) 1994 Modelled IHME
1.89 (1.30 - 2.69) 1993 Modelled IHME
1.92 (1.32 - 2.73) 1992 Modelled IHME
1.93 (1.33 - 2.72) 1991 Modelled IHME
1.93 (1.34 - 2.71) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
191 (125 - 275) 2019 Modelled IHME
186 (123 - 265) 2018 Modelled IHME
180 (119 - 259) 2017 Modelled IHME
175 (116 - 249) 2016 Modelled IHME
172 (113 - 249) 2015 Modelled IHME
165 (109 - 239) 2014 Modelled IHME
159 (107 - 230) 2013 Modelled IHME
155 (104 - 223) 2012 Modelled IHME
150 (101 - 215) 2011 Modelled IHME
143 (96 - 205) 2010 Modelled IHME
135 (91 - 192) 2009 Modelled IHME
131 (89 - 185) 2008 Modelled IHME
127 (85 - 179) 2007 Modelled IHME
122 (81 - 173) 2006 Modelled IHME
117 (79 - 165) 2005 Modelled IHME
113 (76 - 160) 2004 Modelled IHME
109 (72 - 155) 2003 Modelled IHME
106 (71 - 150) 2002 Modelled IHME
103 (68 - 145) 2001 Modelled IHME
100 (67 - 142) 2000 Modelled IHME
99 (66 - 140) 1999 Modelled IHME
96 (64 - 134) 1998 Modelled IHME
92 (62 - 130) 1997 Modelled IHME
90 (61 - 127) 1996 Modelled IHME
87 (59 - 125) 1995 Modelled IHME
86 (58 - 122) 1994 Modelled IHME
84 (58 - 120) 1993 Modelled IHME
83 (57 - 118) 1992 Modelled IHME
81 (56 - 114) 1991 Modelled IHME
79 (55 - 111) 1990 Modelled IHME
74 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
24 (16 - 32) 2019 Modelled IHME
24 (16 - 32) 2018 Modelled IHME
25 (16 - 32) 2017 Modelled IHME
25 (17 - 32) 2016 Modelled IHME
25 (17 - 33) 2015 Modelled IHME
25 (17 - 33) 2014 Modelled IHME
25 (17 - 33) 2013 Modelled IHME
25 (17 - 33) 2012 Modelled IHME
25 (17 - 33) 2011 Modelled IHME
25 (17 - 33) 2010 Modelled IHME
25 (17 - 33) 2009 Modelled IHME
25 (17 - 33) 2008 Modelled IHME
25 (17 - 34) 2007 Modelled IHME
26 (17 - 34) 2006 Modelled IHME
26 (18 - 34) 2005 Modelled IHME
26 (18 - 34) 2004 Modelled IHME
26 (18 - 34) 2003 Modelled IHME
26 (18 - 34) 2002 Modelled IHME
26 (18 - 35) 2001 Modelled IHME
26 (18 - 34) 2000 Modelled IHME
26 (18 - 34) 1999 Modelled IHME
26 (18 - 35) 1998 Modelled IHME
26 (18 - 35) 1997 Modelled IHME
26 (18 - 35) 1996 Modelled IHME
26 (18 - 35) 1995 Modelled IHME
26 (17 - 34) 1994 Modelled IHME
25 (17 - 34) 1993 Modelled IHME
25 (17 - 34) 1992 Modelled IHME
25 (17 - 33) 1991 Modelled IHME
25 (17 - 33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1998
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
None
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
None
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
6.2 (%)
2019
(5.82 - 6.47(%))
IHME
HCV (RNA/cAg+)
1.01 (%)
2019
(0.81 - 1.26(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
289
2019
(200 - 410)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
191
2019
(125 - 275)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
2.30 (%)
2013, survey/surveillance
WHO WPRO, Woodring J et al, 2017

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
25 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources

Programs